Amanote Research
Register
Sign In
Figure 3: The Distributions of Nine-lncRNA Prognostic Signature (A), Overall Survival Status and Overall Survival Time (B) in Model Cohort.
doi 10.7717/peerj.6061/fig-3
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
PeerJ
Related search
Figure 2: The Nine-lncRNA Prognostic Signature to Predict the Overall Survival of Colorectal Cancer Patients.
Figure 5: Performance of Nine-lncRNA Prognostic Signature in Model Cohort: Time-Dependent Receiver Operating Characteristic Curves of Three Prognostic Models According to 1-Year (A), 3-Year (B) and 5-Year (C) Overall Survival. (D) Calibration Curve for 1-Year Overall Survival; (E) Calibration Curve for 3-Year Overall Survival; (F) Calibration Curve for 5-Year Overall Survival.
Figure 8: Performance of Nine-lncRNA Prognostic Signature in Validation Cohort: Time-Dependent Receiver Operating Characteristic Curves of Three Prognostic Models According to 1-Year (A), 3-Year (B) and 5-Year (C) Overall Survival. (D) Calibration Curve for 1-Year Overall Survival; (E) Calibration Curve for 3-Year Overall Survival; (F) Calibration Curve for 5-Year Overall Survival.
Development and Internal Validation of a Nine-lncRNA Prognostic Signature for Prediction of Overall Survival in Colorectal Cancer Patients
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
Figure 3: The Kaplan–Meier Overall Survival Curve.
Figure 3: Survival Analysis of CELSR3 Expression in Terms of Overall Survival (OS).
Figure S2: The Calibration Curves Predicting Overall Survival at (A) 3-Year and (B) 5-Year
Circulating Inflammation Signature Predicts Overall Survival and Relapse-Free Survival in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Prognostic Nomogram for Overall Survival in Patients With Diffuse Large B‐Cell Lymphoma
Oncologist
Cancer Research
Medicine
Oncology
